Weng, Jonathan, et al. “Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease”. Gastroenterology Research, vol. 19, no. 3, Jan. 2026, pp. 147-54, https://doi.org/10.14740/gr2136.